Press Releases
AstraZeneca highlights continued progress of oncology pipeline at ASCO 2016
73 abstracts presented at ASCO with 19 related to Lynparza and new potential medicines targeting DNA damage response in multiple tumour typesContinued momentum of...
News
Chugai set to present Alecensa’s Japanese phase III results at ASCO
Chugai Pharmaceutical Co Ltd announced that the results of the Japanese phase III study (J-ALEX) of Alecensa®, in ALK fusion gene positive NSCLC patients,...
Press Releases
Bayer AG to Showcase Latest Oncology Research at ASCO 2016
Bayer announced that data from several studies across its oncology portfolio will be presented at the 52nd Annual Meeting of the American Society of...
Industry Reports
Merck Increases Sales and Earnings in Q1 Following Sigma-Aldrich Acquisition
Healthcare and Life Science drive Group organic sales growth (+4.7%) Sigma-Aldrich acquisition fuels sales (+20.5%) and EBITDA pre exceptionals (+27.0%) Integration of Sigma-Aldrich...
Press Releases
Spark Therapeutics, Pfizer Inc announce data from initial subjects in hemophilia B trial
Subjects received one-time administration of a highly optimized gene therapy at initial low dose without the need for immunosuppression Therapeutic Factor IX activity...
Press Releases
Merck & Co Inc Final overall survival data from KEYNOTE-006 and KEYNOTE-001 in Advanced Melanoma To Be Presented at 2016 ASCO Annual Meeting
Final Overall Survival Data from KEYNOTE-006 To Be Presented at ASCO; KEYTRUDA, the First Anti-PD-1 Monotherapy to Demonstrate Overall Survival Compared to Ipilimumab, Shows...
News
Valeant Pharmaceuticals To Participate At The UBS Global Healthcare Conference
Valeant Pharmaceuticals International, Inc. announced that Mr. Joseph Papa, Chairman and Chief Executive Officer, will participate at the UBS Global Healthcare Conference to be...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read